JP Morgan Private Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $113M | Sell |
|
|||||
|
2023
Q2 | $147M | Sell |
|
|||||
|
2023
Q1 | $214M | Sell |
|
|||||
|
2022
Q4 | $304M | Buy |
|
|||||
|
2022
Q3 | $258M | Sell |
|
|||||
|
2022
Q2 | $324M | Buy |
|
|||||
|
2022
Q1 | $314M | Buy |
|
|||||
|
2021
Q4 | $340M | Buy |
|
|||||
|
2021
Q3 | $237M | Buy |
|
|||||
|
2021
Q2 | $214M | Buy |
|
|||||
|
2021
Q1 | $177M | Sell |
|
|||||
|
2020
Q4 | $192M | Buy |
|
|||||
|
2020
Q3 | $169M | Buy |
|
|||||
|
2020
Q2 | $126M | Buy |
|
|||||
|
2020
Q1 | $122M | Buy |
|
|||||
|
2019
Q4 | $141M | Buy |
|
|||||
|
2019
Q3 | $124M | Buy |
|
|||||
|
2019
Q2 | $147M | Sell |
|
|||||
|
2019
Q1 | $148M | Buy |
|
|||||
|
2018
Q4 | $142M | Sell |
|
|||||
|
2018
Q3 | $145M | Sell |
|
|||||
|
2018
Q2 | $122M | Buy |
|
|||||
|
2018
Q1 | $110M | Sell |
|
|||||
|
2017
Q4 | $114M | Buy |
|
|||||
|
2017
Q3 | $110M | Buy |
|
|||||
|
2017
Q2 | $97.1M | Buy |
|
|||||
|
2017
Q1 | $98.4M | Buy |
|
|||||
|
2016
Q4 | $91.3M | Sell |
|
|||||
|
2016
Q3 | $96.9M | Buy |
|
|||||
|
2016
Q2 | $99.1M | Sell |
|
|||||
|
2016
Q1 | $84M | Buy |
|
|||||
|
2015
Q4 | $84.8M | Buy |
|
|||||
|
2015
Q3 | $77.2M | Buy |
|
|||||
|
2015
Q2 | $81.1M | Buy |
|
|||||
|
2015
Q1 | $82.3M | Buy |
|
|||||
|
2014
Q4 | $72.9M | Buy |
|
|||||
|
2014
Q3 | $68.5M | Buy |
|
|||||
|
2014
Q2 | $66.6M | Buy |
|
|||||
|
2014
Q1 | $70M | Buy |
|
|||||
|
2013
Q4 | $60.8M | Buy |
|
|||||
|
2013
Q3 | $53.8M | Buy |
|
|||||
|
2013
Q2 | $50M | Buy |
|